Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zley Holdings is a specialized biotechnology company focused on the development and manufacture of high-end pharmaceutical excipients and advanced drug delivery systems. The company provides a comprehensive range of products including PEG derivatives, high-purity phospholipids, and ionizable lipids essential for Lipid Nanoparticle (LNP) formulations used in mRNA vaccines and gene therapies. Zley Holdings operates state-of-the-art R&D and GMP manufacturing facilities in China, serving global pharmaceutical and biotech clients. Their expertise extends to CDMO services for complex injectable formulations and long-acting drug delivery technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zley Holdings.